Vermillion Stock Price (NASDAQ:VRML)

Add to My Stocks
$1.89 $0.02 (1.07%) VRML stock closing price Apr 28, 2017 (Closing)
Prev Close* : $1.87
Market Cap:
Day Low: $1.85
52 Week Low: $0.76
Open: $1.9
Volume: 56054
Day High: $2
52 Week High: $2.85

Latest Stock Market News

Latest Articles

VRML Stockcharts

View VRML PE ratio, PS ratio stocks charts and compare with peers.
VRML Chart
Note: Compare Vermillion stock price history with the index and industry peers.

Vermillion Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

VRML Industry Peers

Company Price Change (%)
Trivascular (TRIV)5.870 (0%)
Viveve Medical (VIVE)8.090.19 (2.41%)
Response Genetics (RGDXQ)00 (0%)
Oncocyte (OCX)5.950 (0%)
Quest Diagnostics (DGX)105.510.3 (0.28%)
Alere (ALR)49.170.07 (0.14%)
Orasure (OSUR)13.110.09 (0.69%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Quotient (QTNT)6.810.25 (3.81%)
IDEXX Laboratories (IDXX)167.734.97 (3.05%)
Accelerate Diagnostics (AXDX)27.30.55 (2.06%)
Varian Medical Systems (VAR)90.741.72 (1.93%)
Cognetix Medical (CGNT)1.840.03 (1.66%)
AngioDynamics (ANGO)15.520.24 (1.57%)
Hologic (HOLX)45.150.57 (1.28%)
Top gainers from Medical Instruments industry
* As of Apr 29, 2017
CompanyPriceChange (%)
APOLLO ENDOSURG (APEN)9.20.41 (4.27%)
Mazor Robotics (MZOR)35.651.2 (3.26%)
Pacific Biosciences Of California (PACB)3.940.12 (2.96%)
Fluidigm (FLDM)4.940.14 (2.76%)
Novadaq Technologies (NVDQ)6.960.12 (1.69%)
CryoLife (CRY)18.150.25 (1.36%)
Veracyte (VCYT)8.470.11 (1.28%)
Top losers from Medical Instruments industry
* As of Apr 29, 2017

Vermillion, Inc. Stock News - Partner Headlines

Vermillion Financial Statements

income statement20152014201320122011
Net Sales Or Revenues2.17M2.52M2.56M2.09M1.92M
Net Income-19.11M-19.2M-8.81M-7.14M-17.79M
Total Operating Expense19.11M20.49M11.25M11.37M19.42M
view Vermillion, Inc. income statement
balance sheet20152014201320122011
Total Assets20.96M24.17M30.64M8.63M23.11M
Total Liabilities3.41M4.91M3.87M3.96M12.75M
Shareholders Equity17.54M19.25M26.76M4.66M10.35M
view Vermillion, Inc. balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-0.41M1.54M0.1M-2.47M0.05M
Net Cash From (Used By) Operating Activities-18.36M-16.8M-8.22M-10.39M-15.58M
Increase (Decrease) In Prop Plant And Equipment-1.05M-0.25M-0.32M-0.01M-0.09M
view Vermillion, Inc. cashflow statement

Vermillion Stock Message Board

Mike-Zaman on Vermillion stock analysis ($1.77)
Watch Vermillion, Inc. (Nasdaq: VRML) closely. The price of its stock soared more than 35% in extended-hours trading on Tuesday, after the company said that it is taking steps to offer OVA1 testing through its wholly-owned subsidiary ASPiRA on behalf of Quest Diagnostics clients. Check this out

Vermillion stock price ended the last trading day at 1.89. The total market value as denoted by 104.89M for Vermillion, is the market value of the company's outstanding shares. A value investor must look at the fundamentals of a stock, and perform Vermillion valuation, even though in the short-term sentiment and current breaking news might affect Vermillion stock price.

For recognizing and analyzing the real performance of Vermillion stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 56054 shares were traded with a closing stock price of 1.89 as of 28 Apr, 2017, as can be seen from Vermillion stock quote. One can view Vermillion stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Vermillion does not pay dividends. To check the historical stock price movement, all time high, and all time low of VRML, view Vermillion stock price history.